Drug Discovery Using Yeast as a Model System: A Functional Genomic and Proteomic View

Author(s): Daniel Auerbach, Anthony Arnoldo, Boris Bogdan, Michael Fetchko, Igor Stagljar

Journal Name: Current Proteomics

Volume 2 , Issue 1 , 2005

Become EABM
Become Reviewer


Drug discovery is a complex process that includes the identification of biological targets as well as the identification of leads that aim at altering or inhibiting the function of a particular target. The budding yeast Saccharomyces cerevisiae has long been recognized as a valuable model organism for studies of eukaryotic cells since many of the basic cellular processes between yeast and humans are highly conserved. In this review, we highlight emerging yeast-based functional genomic and proteomic technologies that are advancing the utility of yeast as a model organism in the drug-discovery process. These approaches include the utilization of yeast deletion strain collection, synthetic genetic array combined with chemical genomics, variations of the yeast two-hybrid system, yeast biosensor assay, and protein microarrays. Although still at an early stage, these technologies show promise as novel and useful methods for development of target-specific therapeutic approaches.

Keywords: drug discovery, yeast two hybrid system, genomics, proteomics

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2005
Page: [1 - 13]
Pages: 13
DOI: 10.2174/1570164053507790

Article Metrics

PDF: 18